Exhibit 107
Calculation of Filing Fee Table
Form S-3
(Form Type)
HOOKIPA Pharma Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1)(2) | Proposed Maximum Offering Price Per Share (3) | Maximum Aggregate Offering Price (3) | Fee Rate | Amount of Registration Fee | |||||||||||||||
| Equity | Common Stock, $0.0001 par value per share | Other | 15,000,000 shares | $ | 0.57175 | $ | 8,576,250.00 | $ | 0.00014760 | $ | 1,265.86 | |||||||||||
| Total Offering Amounts | $ | 8,576,250.00 | $ | 1,265.86 | ||||||||||||||||||
| Total Fees Previously Paid | $ | - | ||||||||||||||||||||
| Total Fee Offsets | $ | - | ||||||||||||||||||||
| Net Fee Due | $ | 1,265.86 | ||||||||||||||||||||
| (1) | Consists of 15,000,000 outstanding shares of the registrant’s common stock. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement also covers such additional shares as may hereafter be offered or issued to prevent dilution resulting from stock splits, stock dividends, recapitalizations or certain other capital adjustments. |
| (2) | Represents the maximum number of shares of common stock that may be offered and sold, from time to time, by the selling stockholder named herein, which shares were issued to the selling stockholder in a private placement. |
| (3) | Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended. The price per share and aggregate offering price are based on the average of the high and low prices of the registrant’s common stock on December 19, 2023, as reported on The Nasdaq Global Select Market. |
